Paolo M. Zambrotta
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: May 21, 2024
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Journal: EClinicalMedicine
Published: November 22, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Journal: Leukemia & lymphoma
Published: November 15, 2023
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: November 10, 2023
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
Journal: Annals of hematology
Published: August 29, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Journal: Hematological oncology
Published: June 27, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 19, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Journal: American journal of hematology
Published: May 24, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Journal: Frontiers in immunology
Published: December 15, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Journal: Cancers
Published: October 11, 2022
Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
Journal: Cancer medicine
Published: September 29, 2022
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Journal: Therapeutic advances in hematology
Published: August 17, 2022
Last Updated: 09/26/2026